Search bioRxiv⌕ Search

Biology subjects

Magnusdottir, S.

Publications and source records attributed to Magnusdottir, S..

6 recordsLinked to original sources

Development of a metabolic signature of post-weaning diarrhoea in pigs

In the agricultural sector, antibiotics have been used to improve swine growth performance. This application is banned nowadays, due to increased risk of antibiotic resistance. In piglets this results in a higher prevalence of post-weaning diarrhoea, deteriorating both animal health and performance. Our goal was to find a metabolite signature separating piglets with low faecal consistency score (FCS) from piglets with normal faecal consistency and determine which pathways were enriched in this signature. By using direct infusion mass spectrometry on blood spots, we built machine learning (ML) models that aimed to differentiate between low and normal FCS. To test the general predictive capability of these models, we applied a Leave-One-Country-Out (LOCO) strategy for cross validation. Our second approach after LOCO was finding the optimal number of features to include in a feature-reduced model. To determine the order in which features were to be eliminated, we ranked them based on a combination of t-test and fold-change significance scores. Enrichment analysis using mummichog was used to gain insights into the final signature set of m/z values found using this ranking and ML models. Models trained both using all countries and leaving out specific countries from training showed a limited ability to predict FCS category. Furthermore, the LOCO results were mixed, with some countries showing a predictive signal present in the data, but others with predictive capability that was no better than random. Signature analysis using t-test and fold-change results did not result in any KEGG pathways that were enriched in this signature as compared to random. Using these methods, we could predict the FCS category to a limited degree. Although no common signature for low faecal consistency could be determined using this method, given that some countries showed more reliable LOCO results, further analysis into specifically the samples from those countries could be a valuable next step. No metabolite signature enriched in changes to KEGG pathways was found in the data using the combined t-test and fold-change analysis ranking method. We have shared the data with the community through the MetaboLights repository.

bioinformatics↗

Simulation of 69 microbial communities indicates sequencing depth and false positives are major drivers of bias in Prokaryotic metagenome-assembled genome recovery

We hypothesize that sample evenness, sequencing depth and taxonomic relatedness influence the recovery of metagenome-assembled genomes (MAGs). To test this hypothesis, we assessed MAG recovery in three in silico microbial communities composed of 42 species with the same richness but different sample evenness, sequencing depth and taxonomic distribution profiles using three different pipelines for MAG recovery. The pipeline developed by Parks and colleagues (8K) generated the highest number of MAGs and the lowest number of true positives per community profile. The pipeline by Karst and colleagues (DT) showed the most accurate results ([~] 92%), outperforming the 8K and Multi-Metagenome pipeline (MM) developed by Albertsen and collaborators. Sequencing depth influenced the accurate recovery of genomes when using the 8K and MM, even with contrasting patterns: the MM pipeline recovered more MAGs found in the original communities when employing sequencing depths up to 60 million reads, whilst the 8K recovered more true positives in communities sequenced above 60 million reads. DT showed the best species recovery from the same genus, even though close-related species have a low recovery rate in all pipelines. Our results highlight that more bins do not translate to the actual community composition and that sequencing depth plays a role in MAG recovery and increased community resolution. Even low MAG recovery error rates can significantly impact biological inferences. Our data indicates the scientific community should their findings from MAG recovery, especially when asserting novel species or metabolic traits.

bioinformatics↗

AGORA2: Large scale reconstruction of the microbiome highlights wide-spread drug-metabolising capacities.

The human microbiome influences the efficacy and safety of a wide variety of commonly prescribed drugs, yet comprehensive systems-level approaches to interrogate drug-microbiome interactions are lacking. Here, we present a computational resource of human microbial genome-scale reconstructions, deemed AGORA2, which accounts for 7,206 strains, includes microbial drug degradation and biotransformation, and was extensively curated based on comparative genomics and literature searches. AGORA2 serves as a knowledge base for the human microbiome and as a metabolic modelling resource. We demonstrate the latter by mechanistically modelling microbial drug metabolism capabilities in single strains and pairwise models. Moreover, we predict the individual-specific drug conversion potential in a cohort of 616 colorectal cancer patients and controls. This analysis reveals that some drug activation capabilities are present in only a subset of individuals, moreover, drug conversion potential correlate with clinical parameters. Thus, AGORA2 paves the way towards personalised, predictive analysis of host-drug-microbiome interactions.

systems biology↗

MetaboShiny - interactive processing, analysis and identification of untargeted metabolomics data

Direct infusion untargeted metabolomics, as mass-over-charge values and intensity of ions, allows for rapid insight into a samples metabolic activity. However, analysis is often complicated by the large array of detected m/z values and the difficulty to prioritize important m/z and simultaneously annotate their putative identities. To address this challenge, we developed MetaboShiny, a novel R/RShiny-based metabolomics package featuring data analysis, database- and formula-prediction-based annotation and visualization. To demonstrate this, we reproduce and further explore a MetaboLights metabolomics bioinformatics study on lung cancer patient urine samples. MetaboShiny enables rapid and rigorous analysis and interpretation of direct infusion untargeted metabolomics data.

bioinformatics↗

The Virtual Metabolic Human database: integrating human and gut microbiome metabolism with nutrition and disease

A multitude of factors contribute to complex diseases and can be measured with \"omics\" methods. Databases facilitate data interpretation for underlying mechanisms. Here, we describe the Virtual Metabolic Human (VMH, http://vmh.life) database encapsulating current knowledge of human metabolism within five interlinked resources \"Human metabolism\", \"Gut microbiome\", \"Disease\", \"Nutrition\", and \"ReconMaps\". The VMH captures 5,180 unique metabolites, 17,730 unique reactions, 3,288 human genes, 255 Mendelian diseases, 818 microbes, 632,685 microbial genes, and 8,790 food items. The VMHs unique features are i) the hosting the metabolic reconstructions of human and gut microbes amenable for metabolic modeling; ii) seven human metabolic maps for data visualization; iii) a nutrition designer; iv) a user-friendly webpage and application-programming interface to access its content; and v) user feedback option for community engagement. We demonstrate with four examples the VMHs utility. The VMH represents a novel, interdisciplinary database for data interpretation and hypothesis generation to the biomedical community.

systems biology↗

The Microbiome Modeling Toolbox: from microbial interactions to personalized microbial communities

MotivationThe application of constraint-based modeling to functionally analyze metagenomic data has been limited so far, partially due to the absence of suitable toolboxes.\n\nResultsTo address this shortage, we created a comprehensive toolbox to model i) microbe-microbe and host-microbe metabolic interactions, and ii) microbial communities using microbial genome-scale metabolic reconstructions and metagenomic data. The Microbiome Modeling Toolbox extends the functionality of the COBRA Toolbox.\n\nAvailabilityThe Microbiome Modeling Toolbox and the tutorials at https://git.io/microbiomeModelingToolbox.

systems biology↗